The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid

British Journal of Rheumatology

Volumn 35, Issue 10, 1996, Pages 951-957

  Sharif, M ^a,c   Osborne, D J ^b   Meadows, K ^a   Woodhouse, S M ^b   Colvin, E M ^b   Shepstone, L ^a   Dieppe, P A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Normal synovial fluid; Osteoarthritis; Rheumatoid arthritis; Unsaturated chondroitin sulphate disaccharides

Indexed keywords

CHONDROITIN; DISACCHARIDE; GLYCOSAMINOGLYCAN; KERATAN SULFATE;

ADULT; AGE; AGED; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CAPILLARY ELECTROPHORESIS; CARTILAGE DEGENERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SULFATION; SYNOVIAL FLUID;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARTILAGE; CHONDROITIN; DISACCHARIDES; EPITOPE MAPPING; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; KERATAN SULFATE; LINEAR MODELS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SEX FACTORS; SULFUR; SYNOVIAL FLUID;

EID: 0029965555     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Heinegard D, Saxne T. Molecular markers of processes in cartilage in joint disease. Br J Rheumatol 1991;30:21-4.
2. Mehraban F, Finegan CK, Moskowitz RW. Serum keratan sulfate: Quantitative and qualitative comparisons in inflammatory versus non-inflammatory arthritides. Arthritis Rheum 1991;34:383-92.
3. Spector TD, Woodward L, Hall GM et al. Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases. Ann Rheum Dis 1992;51:1134-7.
4. Thonar EJ-MA, Lenz ME, Klintworth GK et al. Quantification of keratan sulphate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-76.
5. Saxne T, Heinegård D. Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583-91.
6. Saxne T, Heinegard D, Wollheim FA, Pettersson H. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 1986;2:127-8.
7. Sharif M, George E, Shepstone L et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995;38:760-7.
8. Sharif M, Saxne T, Shepstone L et al. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995;34:306-10.
9. Creamer P, Sharif M, George E, Cushnaghan J, Dieppe P. Intra-articular hyaluronic acid in osteoarthritis of the knee joint: an investigation into mechanisms of action. Osteoarthritis Cartilage 1994;2:133-40.
10. Brandt KD. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers. J Rheumatol 1989;18:39-42.
11. George E, Sharif M, Dieppe P. Insulin-like growth factor-1 and biochemical markers of osteoarthritis. Br J Rheumatol 1993;32:265-7.
12. Dieppe PA, Kirwan JR. The localization of osteoarthritis. Br J Rheumatol 1994;33:201-4.
13. Slater RR, Caterson B, Lachiewicz P, Bayliss MT. The occurrence of 3B3 (-) and 7D4 epitopes as markers of arthritis in humans. Trans Orthop Res Soc 1992;17:277.
14. Ratcliffe A, Shurety W, Caterson B. The quantitation of a native chondroitin sulphate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum 1993;36:543-50.
15. Poole AR, Ionescu M, Swan A, Dieppe P. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan: Implications for pathogenesis. J Clin Invest 1994;94:25-33.
16. Sweet MB, Coelho A, Schnitzler CM et al. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 1988;31:648-52.
17. Michelacci YM, Mourao PAS, Laredo J, Dietrich CP. Chondroitin sulfates and proteoglycans from normal and arthrosic human cartilage. Connect Tissue Res 1979;7:29-36.
18. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulphate and chondroitin 6-sulphate in pathological joint fluid. Arthritis Rheum 1992;35:1304-8.
19. Saxne T, Wollheim FA, Pettersson H, Heinegard D. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis? Br Med J 1987;295:1447-8.
20. Campion GV, McCrae F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ-MA. Levels of keratan sulphate in serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-9.
21. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis 1957;16:494-502.
22. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-7.
24. Caterson B, Christner JE, Baker JR, Couchman JR. Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc 1985;44:386-93.
25. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984;307:650-2.
26. Caterson B, Mahmoodian F, Sorrell JM et al. Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci 1990;97:411-7.
27. Osbone D, Woodhouse S, Meacock R. Early changes in the sulphation of chondroitin in Guinea-pig articular cartilage, a possible predictor of osteoarthritis. Osteoarthritis Cartilage 1994;2:215-23.
28. Saxne T, Heinegard D, Wollheim FA. Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment. Arthritis Rheum 1987;30:972-9.
29. Lohmender LS, Dahlberg L, Ryd L, Heinegard D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 1989;32:1434-42.
30. Ryu J, Treadwell BV, Mankin HJ. Biochemical and metabolic abnormalities in normal and osteoarthritic human articular cartilage. Arthritis Rheum 1984;27:49-56.
31. Worrall JG, Wilkinson LS, Bayliss MT, Edwards JCW. Zonal distribution of chondroitin-4-sulphate/dermatan sulphate and chondroitin-6-sulphate in normal and diseased human synovium. Ann Rheum Dis 1994;53:35-8.
32. Van Saase JLCM, Van Romunde LKJ, Cats A, Vanderbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-80.
33. Engel A, Roberts J, Burch TA. Rheumatoid arthritis in adults: United States, 1960-1962. Vital Statistics, National Center for Health Statistics, DHEW, Series 11 No. 17, 1966.
34. Mourau PAS. Distribution of chondroitin 4-sulfate and chondroitin 6-sulfate in human articular and growth cartilage. Arthritis Rheum 1988;31:1028-33.
35. Bayliss M, Davidson C, Woodhouse SM, Osborne DJ. Chondroitin sulphation in human joint tissues varies with age, zone and topography. Acta Orthop Scand 1995;66:22-5.
36. Ismail S, Atkins RM, Pearse MF, Dieppe PA, Elson CJ. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli. Br J Rheumatol 1992;31:369-73.
37. Arner EC. Effect of animal age and chronicity of interleukin-1 exposure on cartilage proteoglycan depletion in vivo. J Orthop Res 1994;12:321-30.
38. Shingu M, Miyauchi S, Nagai Y, Yasutake C, Horie K. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. Br J Rheumatol 1995;34:101-6.
39. Burkhardt D, Michel BA, Baici A, Kissling R, Theiler R. Comparison of chondroitin sulphate composition of femoral head articular cartilage from patients with femoral neck fractures and osteoarthritis and controls. Rheumatol Int 1995;14:235-41.